Dr. Reddy's Laboratories News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

27.03.17	Dr. Reddy's To Market Integra's DuraGen Product Line In India - Quick Facts (RTTNews)
16.03.17	CytoSorbents Announces CytoSorb® Partnership with Dr. Reddy's Laboratories (PR Newswire)
08.02.17	Dr. Reddy's étend ses opérations commerciales en Europe (PR Newswire)
08.02.17	Dr. Reddy's Expands Commercial Operations in Europe (PR Newswire)
03.02.17	Lifshitz & Miller LLP Announces Investigation of Dr. Reddy's Laboratories Limited, Exterran Corporation, Gigamon Inc., KemPharm, Inc., Navient Corporation, NCI, Inc., Opus Bank, PixarBio... (PR Newswire)
25.01.17	Johnson & Weaver, LLP Announces Investigations of Pearson plc., BT Group plc, Dr. Reddy's Laboratories Ltd. and OneMain Holdings, Inc. (PR Newswire)
24.01.17	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Dr. Reddy's Laboratories Limited (RDY) (PR Newswire)
11.11.16	Dr. Reddy's Labs Launches Raloxifene HCl Tablets, USP In U.S. Market (RTTNews)
13.10.16	Dr. Reddy's Labs Launches Aripiprazole Tablets, USP Tablets In U.S. (RTTNews)
10.10.16	Dr. Reddy's Labs Launches Lamotrigine Orally Disintegrating Tablets In U.S. (RTTNews)
16.09.16	Dr. Reddy's Expands Collaboration To Market Amgen's 3 Medicines In India (RTTNews)
29.08.16	Dr. Reddy's Labs Launches Nitroglycerin Sublingual Tablets USP (RTTNews)
25.05.16	Dr. Reddy's Buys Six OTC Brands From Ducere Pharma; Terms Not Disclosed (RTTNews)
19.04.16	Dr. Reddy's ZEMBRACE SymTouch Migraine Injection Commercially Available In U.S (RTTNews)
31.03.16	Dr. Reddy's Acquires Rights For Anticancer Agent E7777 From Eisai (RTTNews)
28.03.16	Dr. Reddy's Granted U.S. Rights For XenoPort's Clinical-stage XP23829 (RTTNews)
11.03.16	Dr. Reddy's, TR-Pharm Collaborate For Manufacture Of Biosimilar Drugs In Turkey (RTTNews)
09.02.16	Dr. Reddy's Labs Q3 Profit Edges Up, Revenues Rise - Quick Facts (RTTNews)
08.02.16	Dr. Reddy's Says Sernivo Spray 0.05% For Plaque Psoriasis Gets FDA Approval (RTTNews)
02.02.16	ABT Gets Bigger, Just One More To Go For CHRS, CBYL Pained, REPH On Watch (RTTNews)
29.01.16	Dr. Reddy's Gets FDA Approval For Migraines Injection ZEMBRACESymTouch (RTTNews)
30.12.15	Dr. Reddy's Re-launches Esomeprazole Magnesium Delayed-Release Capsules (RTTNews)
18.11.15	Dr. Reddy's Closes $17.5 Mln Purchase Of Fondaparinux IP Rights From Alchemia (RTTNews)
10.11.15	Generic Nexium Blocked In US (RTTNews)
10.11.15	Dr. Reddy's Statement On Temporary Restraining Order For Esomeprazole Capsules (RTTNews)
06.11.15	Dr. Reddy's Gets FDA Warning Letter, To Fully Comply With CGMP Quality Standards (RTTNews)
02.11.15	Dr. Reddy's Labs Launches Nise D Spray For Quick, Targeted Pain Killing (RTTNews)
02.10.15	Sucampo Pharmaceuticals, Inc -- Moody's assigns B3 CFR to Sucampo Pharmaceuticals (Moodys)
28.09.15	Dr. Reddy's Launches Esomeprazole Magnesium Delayed-Release Capsules (RTTNews)
18.09.15	BioMarin Announces Kuvan Patent Challenge Settlement (RTTNews)
14.09.15	Dr. Reddy's Labs Signs Commercialization Deal With Hatchtech - Quick Facts (RTTNews)
10.09.15	Dr. Reddy's Signs Supply And Licensing Deal With PanTheryx For DiaResQ (RTTNews)
13.07.15	Dr. Reddy's Labs Unveils Generic Version Of NAMENDA Tablets In US - Quick Facts (RTTNews)
08.04.15	Dr. Reddy's Labs Announce Filing Of Three NDAs With U.S FDA - Quick Facts (RTTNews)
01.04.15	Dr. Reddy's To Acquire Select Brands Portfolio Of UCB - Quick Facts (RTTNews)
21.01.15	Curis And Aurigene Announce Collaboration Agreement - Quick Facts (RTTNews)
16.12.14	Dr Reddy's Launches Valganciclovir Tablets USP 450 Mg - Quick Facts (RTTNews)
20.11.14	Dr. Reddy's Launches Generic Version Of Allegra-D 12 Hour (RTTNews)
14.05.14	Dr. Reddy's Labs To Separate Roles Of Chairman, Managing Director & CEO (RTTNews)
23.04.14	Dr. Reddy's Launches Fenofibrate Capsules, USP 43 Mg And 130 Mg In U.S. (RTTNews)
16.04.14	Dr. Reddy's Laboratories Launches Eszopiclone Tablets In U.S. - Quick Facts (RTTNews)
05.03.14	Dr. Reddy's Labs Launches Moxifloxacin Hydrochloride Tablets (RTTNews)
26.09.13	FDA Approvals, New Appointments, Positive Litigation Outcomes and Partnerships - Research Report on Edwards Lifesciences, Illumina, Teva, Alere, and Dr. Reddy's (PR Newswire)
17.09.13	Dr. Reddy's Reports Approval Of Azacitidine For Injection - Quick Facts (RTTNews)
02.09.13	Acquisitions, NDA Filings, Key Findings, Conferences and Product Launches - Research Report on Perrigo, Forest Labs, Avanir Pharmaceuticals, Cubist Pharmaceuticals, and Dr. Reddy's Laboratories (PR Newswire)
28.07.13	Dr. Reddy's Launches Donepezil Hydrochloride Tablets In U.S. - Quick Facts (RTTNews)
25.07.13	Settlements, Significant Study Results, and Product Launches Lead to Advancements in Patient Care - Research Report on GSK, Isis, Endo, Pacira, and Dr. Reddy's (PR Newswire)
20.07.12	Dr. Reddy's enttäuscht Erwartungen (EMFIS)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

06.11.24		Gewinne in New York: NASDAQ Composite zum Ende des Mittwochshandels mit positivem Vorzeichen
06.11.24		Aufschläge in New York: NASDAQ Composite verbucht am Mittwochnachmittag Gewinne
06.11.24		Mittwochshandel in New York: NASDAQ Composite liegt mittags im Plus
21.10.24		Minuszeichen in New York: NASDAQ Composite am Montagmittag leichter
15.10.24		Schwacher Handel in New York: NASDAQ Composite legt schlussendlich den Rückwärtsgang ein
15.10.24		Freundlicher Handel in New York: NASDAQ Composite verbucht zum Start des Dienstagshandels Zuschläge
04.09.24		Handel in New York: NASDAQ Composite startet in der Verlustzone
14.08.24		NASDAQ Composite aktuell: NASDAQ Composite bewegt sich mittags im Plus

06.11.24

Gewinne in New York: NASDAQ Composite zum Ende des Mittwochshandels mit positivem Vorzeichen

06.11.24

Aufschläge in New York: NASDAQ Composite verbucht am Mittwochnachmittag Gewinne

06.11.24

Mittwochshandel in New York: NASDAQ Composite liegt mittags im Plus

21.10.24

Minuszeichen in New York: NASDAQ Composite am Montagmittag leichter

15.10.24

Schwacher Handel in New York: NASDAQ Composite legt schlussendlich den Rückwärtsgang ein

15.10.24

Freundlicher Handel in New York: NASDAQ Composite verbucht zum Start des Dienstagshandels Zuschläge